These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

It was a busy week for the biotech sector, as the fourth-quarter earnings season is in full swing. While Gilead Sciences, Inc ...

Moleculin Biotech received FDA guidance reducing its Phase 3 trial size for Annamycin in AML. First unblinding is expected in ...

Financing led by Velan Capital with participation from new and existing healthcare-focused institutional investors and ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

To illustrate that point, let's discuss two stocks in the biotech industry that have moved in opposite directions so far this ...

Biotech investing can be tricky. Often, the drugs that these fledgling companies produce don’t pan out, and shareholders take ...

LIXTE Biotechnology (LIXT) announced the closing of its previously announced registered direct offering priced at-the-market ...

AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...

Sumitomo Mitsui Trust Group Inc. lowered its stake in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 2.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & ...